Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Sumitomo Pharma Co., Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2028 | $581.00B | $516.70B - $641.40B | -$44.01B | $0.00 | 7 |
| Mar 2027 | $544.98B | $530.20B - $566.30B | -$41.29B | $0.00 | 6 |
| Mar 2026 | $440.80B | $408.60B - $463.65B | -$33.39B | $0.00 | 7 |
| Mar 2025 | $372.55B | $344.20B - $382.98B | -$28.22B | $0.00 | 8 |